<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Emerging evidence has demonstrated that microRNAs (miRNAs) can act as oncogenes or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors to participate in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we found that miR-429 expression was up-regulated in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) tissues, and the high miR-429 expression was significantly associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and poor prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>Functionally, miR-429 overexpression suppressed cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by directly targeting SOX2 in HT-29 cells </plain></SENT>
<SENT sid="3" pm="."><plain>Taken together, our data suggest for the first time that miR-429 could play an oncogenic role in the cellular processes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and represent a novel prognostic biomarker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>